Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
All cholesterol except HDL; captures total atherogenic cholesterol burden. Non-HDL cholesterol is measured by blood test as part of the Cardiovascular panel in the HodieLabs Health Blueprint.
Non-HDL = TC - HDL-C; captures atherogenic cholesterol missed by LDL-C alone. Particularly useful when TG are elevated (>2.0 mmol/L) as LDL-C becomes less reliable.
Associated risks when out of range: Captures all atherogenic cholesterol (LDL + VLDL + IDL + Lp(a)). Superior to LDL-C in patients with elevated triglycerides, Does not require fasting, a practical advantage over calculated LDL.
The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Non-HDL cholesterol, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.
The HodieLabs Evidence-Based Clinical Library interprets Non-HDL cholesterol against published clinical authority standards, never arbitrary "optimal" ranges. Measured in mmol/L:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Non-HDL cholesterol is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.
2. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41:111–188.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
All cholesterol except HDL; captures total atherogenic cholesterol burden.
The HodieLabs Evidence-Based Clinical Library optimal range is <3.4 mmol/L, based on ESC-EAS 2019 dyslipidaemia guidelines; non-HDL-C <3.4 mmol/L for moderate-risk primary prevention.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: calculate as total cholesterol minus hdl-c, no special test needed, target <3.0 mmol/l for longevity; <2.6 for high-risk individuals. Interpretation and an action plan should always involve your doctor.
Non-HDL cholesterol is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Non-HDL cholesterol and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.